{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:23:18Z","timestamp":1791318198521,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00198-023-06803-w","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T10:03:21Z","timestamp":1685354601000},"page":"1613-1623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-7874","authenticated-orcid":false,"given":"K.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-m.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9403-752X","authenticated-orcid":false,"given":"Q.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8695-4048","authenticated-orcid":false,"given":"Y.-q.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-221X","authenticated-orcid":false,"given":"C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"issue":"1","key":"6803_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11657-017-0372-x","volume":"12","author":"F Bachour","year":"2017","unstructured":"Bachour F, Rizkallah M, Sebaaly A, Barakat A, Razzouk H, El Hage R et al (2017) Fracture liaison service: report on the first successful experience from the Middle East. Arch Osteoporos 12(1):79","journal-title":"Arch Osteoporos"},{"issue":"3","key":"6803_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11914-010-0023-2","volume":"8","author":"TA van Geel","year":"2010","unstructured":"van Geel TA, Huntjens KM, van den Bergh JP, Dinant GJ, Geusens PP (2010) Timing of subsequent fractures after an initial fracture. Curr Osteoporos Rep 8(3):118\u2013122","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"6803_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.2008.092775","volume":"68","author":"TA van Geel","year":"2009","unstructured":"van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68(1):99\u2013102","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6803_CR4","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1210\/jc.2017-02656","volume":"103","author":"T Tran","year":"2018","unstructured":"Tran T, Bliuc D, Hansen L, Abrahamsen B, van den Bergh J, Eisman JA et al (2018) Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis. J Clin Endocrinol Metab 103(9):3205\u20133214","journal-title":"J Clin Endocrinol Metab"},{"issue":"9156","key":"6803_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353(9156):878\u2013882","journal-title":"Lancet"},{"key":"6803_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1196\/annals.1346.041","volume":"1068","author":"RG Russell","year":"2006","unstructured":"Russell RG (2006) Bisphosphonates: from bench to bedside. Ann N Y Acad Sci 1068:367\u2013401","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"6803_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00198-007-0367-3","volume":"18","author":"JP Devogelaer","year":"2007","unstructured":"Devogelaer JP, Brown JP, Burckhardt P, Meunier PJ, Goemaere S, Lippuner K et al (2007) Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporos Int 18(9):1211\u20131218","journal-title":"Osteoporos Int"},{"issue":"9671","key":"6803_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","volume":"373","author":"DM Reid","year":"2009","unstructured":"Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY et al (2009) Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 373(9671):1253\u20131263","journal-title":"Lancet"},{"issue":"18","key":"6803_CR9","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799\u20131809","journal-title":"N Engl J Med"},{"issue":"18","key":"6803_CR10","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","volume":"367","author":"S Boonen","year":"2012","unstructured":"Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B et al (2012) Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med 367(18):1714\u20131723","journal-title":"N Engl J Med"},{"issue":"10","key":"6803_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10067-010-1486-3","volume":"29","author":"M Maricic","year":"2010","unstructured":"Maricic M (2010) The role of zoledronic acid in the management of osteoporosis. Clin Rheumatol 29(10):1079\u20131084","journal-title":"Clin Rheumatol"},{"issue":"18","key":"6803_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u20131822","journal-title":"N Engl J Med"},{"issue":"9","key":"6803_CR13","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95(9):4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6803_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jbmr.4434","volume":"37","author":"DM Black","year":"2022","unstructured":"Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T et al (2022) The interaction of acute-phase reaction and efficacy for osteoporosis after zoledronic acid: HORIZON Pivotal Fracture Trial. J Bone Min Res Official J Am Soc Bone Min Res 37(1):21\u201328","journal-title":"J Bone Min Res Official J Am Soc Bone Min Res"},{"key":"6803_CR15","doi-asserted-by":"publisher","first-page":"991913","DOI":"10.3389\/fendo.2022.991913","volume":"13","author":"K Lu","year":"2022","unstructured":"Lu K, Shi Q, Gong YQ, Li C (2022) Association between vitamin D and zoledronate-induced acute-phase response fever risk in osteoporotic patients. Front Endocrinol (Lausanne). 13:991913","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"11","key":"6803_CR16","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00198-022-06493-w","volume":"33","author":"K Lu","year":"2022","unstructured":"Lu K, Shi Q, Gong YQ, Shao JW, Li C (2022) Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate. Osteoporos Int 33(11):2381\u20132396","journal-title":"Osteoporos Int"},{"issue":"2","key":"6803_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00198-011-1563-8","volume":"23","author":"JD Wark","year":"2012","unstructured":"Wark JD, Bensen W, Recknor C, Ryabitseva O, Chiodo J 3rd, Mesenbrink P et al (2012) Treatment with acetaminophen\/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg. Osteoporos Int 23(2):503\u2013512","journal-title":"Osteoporos Int"},{"issue":"2","key":"6803_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00774-019-01050-8","volume":"38","author":"N Okimoto","year":"2020","unstructured":"Okimoto N, Sakai A, Yoshioka T, Kobayashi T, Asano K, Akahoshi S et al (2020) Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study. J Bone Miner Metab 38(2):230\u2013239","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"6803_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"9","key":"6803_CR20","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1097\/CORR.0000000000001772","volume":"479","author":"NH Varady","year":"2021","unstructured":"Varady NH, Gillinov SM, Yeung CM, Rudisill SS, Chen AF (2021) The Charlson and Elixhauser scores outperform the American Society of Anesthesiologists Score in assessing 1-year mortality risk after hip fracture surgery. Clin Ortho Related Res 479(9):1970\u20131979","journal-title":"Clin Ortho Related Res"},{"issue":"11","key":"6803_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130\u20131139","journal-title":"Med Care"},{"issue":"6","key":"6803_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676\u2013682","journal-title":"Am J Epidemiol"},{"issue":"11","key":"6803_CR23","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00198-016-3643-2","volume":"27","author":"KF Axelsson","year":"2016","unstructured":"Axelsson KF, Jacobsson R, Lund D, Lorentzon M (2016) Effectiveness of a minimal resource fracture liaison service. Osteoporos Int. 27(11):3165\u20133175","journal-title":"Osteoporos Int."},{"issue":"25","key":"6803_CR24","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","volume":"343","author":"WN Kernan","year":"2000","unstructured":"Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E et al (2000) Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343(25):1826\u20131832","journal-title":"N Engl J Med"},{"issue":"446","key":"6803_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496\u2013509","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"6803_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1078155207080806","volume":"13","author":"K Olson","year":"2007","unstructured":"Olson K, Van Poznak C (2007) Significance and impact of bisphosphonate-induced acute phase responses. J Oncol Pharm Pract 13(4):223\u2013229","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"6803_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00223-021-00884-7","volume":"109","author":"M Shiraki","year":"2021","unstructured":"Shiraki M, Kuroda T, Takeuchi Y, Sugimoto T, Tanaka S, Suzuki H et al (2021) Acute phase reactions after intravenous infusion of zoledronic acid in Japanese patients with osteoporosis: sub-analyses of the Phase III ZONE Study. Calcif Tissue Int 109(6):666\u2013674","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"6803_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/os.12338","volume":"9","author":"Y Ding","year":"2017","unstructured":"Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX et al (2017) Multicenter study on observation of acute-phase responses after infusion of zoledronic acid 5\u2009mg in Chinese Women with postmenopausal osteoporosis. Orthop Surg 9(3):284\u2013289","journal-title":"Orthop Surg"},{"issue":"2","key":"6803_CR29","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3892\/etm.2017.4646","volume":"14","author":"J Chen","year":"2017","unstructured":"Chen J, Yu L, Chen L, Wu X, Tang P, Yin J et al (2017) Surgical trauma and low-dose methylprednisolone modulate the severity of the acute-phase response induced by zoledronic acid infusion. Exp Ther Med 14(2):1802\u20131808","journal-title":"Exp Ther Med"},{"issue":"20 Pt 2","key":"6803_CR30","doi-asserted-by":"publisher","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12(20 Pt 2):6222s\u20136230s","journal-title":"Clin Cancer Res"},{"issue":"7","key":"6803_CR31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1517\/14728222.11.7.941","volume":"11","author":"S Galluzzo","year":"2007","unstructured":"Galluzzo S, Santini D, Vincenzi B, Caccamo N, Meraviglia F, Salerno A et al (2007) Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity. Expert Opin Ther Targets 11(7):941\u2013954","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"6803_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448\u2013454","journal-title":"N Engl J Med"},{"issue":"1","key":"6803_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bja\/85.1.109","volume":"85","author":"JP Desborough","year":"2000","unstructured":"Desborough JP (2000) The stress response to trauma and surgery. Br J Anaesth 85(1):109\u2013117","journal-title":"Br J Anaesth"},{"issue":"Suppl 1","key":"6803_CR34","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4\u2013S9","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"6803_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","volume":"70","author":"L Capuron","year":"2011","unstructured":"Capuron L, Schroecksnadel S, F\u00e9art C, Aubert A, Higueret D, Barberger-Gateau P et al (2011) Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70(2):175\u2013182","journal-title":"Biol Psychiatry"},{"issue":"2","key":"6803_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","volume":"121","author":"H Bruunsgaard","year":"2000","unstructured":"Bruunsgaard H, Skinh\u00f8j P, Pedersen AN, Schroll M, Pedersen BK (2000) Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 121(2):255\u2013260","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"6803_CR37","doi-asserted-by":"publisher","first-page":"M357","DOI":"10.1093\/gerona\/54.7.M357","volume":"54","author":"H Bruunsgaard","year":"1999","unstructured":"Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinh\u00f8j P, Pedersen BK (1999) A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54(7):M357\u2013M364","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"6803_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000022157","volume":"46","author":"Y Hasegawa","year":"2000","unstructured":"Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A (2000) Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 46(4):185\u2013188","journal-title":"Gerontology"},{"issue":"6","key":"6803_CR39","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1182\/blood-2004-07-2599","volume":"105","author":"L Ferrucci","year":"2005","unstructured":"Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD et al (2005) The origins of age-related proinflammatory state. Blood 105(6):2294\u20132299","journal-title":"Blood"},{"issue":"4","key":"6803_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000337051","volume":"127","author":"MC Garc\u00eda-Dabrio","year":"2012","unstructured":"Garc\u00eda-Dabrio MC, Pujol-Moix N, Martinez-Perez A, Fontcuberta J, Souto JC, Soria JM et al (2012) Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study. Acta Haematol 127(4):244\u2013249","journal-title":"Acta Haematol"},{"issue":"13-14","key":"6803_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/15287394.2015.1051170","volume":"78","author":"V Valdiglesias","year":"2015","unstructured":"Valdiglesias V, S\u00e1nchez-Flores M, Maseda A, Marcos-P\u00e9rez D, Mill\u00e1n-Calenti JC, P\u00e1saro E et al (2015) Lymphocyte subsets in a population of nonfrail elderly individuals. J Toxicol Environ Health A 78(13-14):790\u2013804","journal-title":"J Toxicol Environ Health A"},{"issue":"8","key":"6803_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2217\/imt.13.77","volume":"5","author":"AL de Ara\u00fajo","year":"2013","unstructured":"de Ara\u00fajo AL, Silva LC, Fernandes JR, Benard G (2013) Preventing or reversing immunosenescence: can exercise be an immunotherapy? Immunotherapy 5(8):879\u2013893","journal-title":"Immunotherapy"},{"issue":"3","key":"6803_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.yexmp.2005.11.004","volume":"80","author":"M De Martinis","year":"2006","unstructured":"De Martinis M, Franceschi C, Monti D, Ginaldi L (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80(3):219\u2013227","journal-title":"Exp Mol Pathol"},{"key":"6803_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fimmu.2013.00271","volume":"4","author":"T F\u00fcl\u00f6p","year":"2013","unstructured":"F\u00fcl\u00f6p T, Larbi A, Pawelec G (2013) Human T cell aging and the impact of persistent viral infections. Front Immunol 4:271","journal-title":"Front Immunol"},{"issue":"3","key":"6803_CR45","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"E Montecino-Rodriguez","year":"2013","unstructured":"Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest 123(3):958\u2013965","journal-title":"J Clin Invest"},{"issue":"3","key":"6803_CR46","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"6803_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392\u2013397","journal-title":"J Am Med Dir Assoc"},{"key":"6803_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","volume":"31","author":"P Soysal","year":"2016","unstructured":"Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R et al (2016) Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev 31:1\u20138","journal-title":"Ageing Res Rev"},{"issue":"3","key":"6803_CR49","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","volume":"154","author":"I Bjarnason","year":"2018","unstructured":"Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A (2018) Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 154(3):500\u2013514","journal-title":"Gastroenterology"},{"issue":"4","key":"6803_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","volume":"26","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL (2015) Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Eur J Intern Med 26(4):285\u2013291","journal-title":"Eur J Intern Med"},{"issue":"8","key":"6803_CR51","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/jbmr.4534","volume":"37","author":"G Adami","year":"2022","unstructured":"Adami G, Fassio A, Gatti D, Viapiana O, Rossini M (2022) Acute phase reaction and fracture risk reduction: are gamma-delta T cells and hypovitaminosis D the missing link? J Bone Min Res Official J Am Soc Bone Min Res 37(8):1622","journal-title":"J Bone Min Res Official J Am Soc Bone Min Res"},{"issue":"9","key":"6803_CR52","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/jbmr.2245","volume":"29","author":"KE Barbour","year":"2014","unstructured":"Barbour KE, Lui LY, Ensrud KE, Hillier TA, LeBlanc ES, Ing SW et al (2014) Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Min Res Official J Am Soc Bone Min Res 29(9):2057\u20132064","journal-title":"J Bone Min Res Official J Am Soc Bone Min Res"},{"issue":"3","key":"6803_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1359\/jbmr.090819","volume":"25","author":"F Bertoldo","year":"2010","unstructured":"Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M et al (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Min Res Official J Am Soc Bone Min Res 25(3):447\u2013454","journal-title":"J Bone Min Res Official J Am Soc Bone Min Res"},{"issue":"2","key":"6803_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2106\/JBJS.D.01772","volume":"87","author":"M Bhandari","year":"2005","unstructured":"Bhandari M, Bajammal S, Guyatt GH, Griffith L, Busse JW, Sch\u00fcnemann H et al (2005) Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 87(2):293\u2013301","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"6803_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2106\/JBJS.G.01193","volume":"91","author":"G Friedl","year":"2009","unstructured":"Friedl G, Radl R, Stihsen C, Rehak P, Aigner R, Windhager R (2009) The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial. J Bone Joint Surg Am 91(2):274\u2013281","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"6803_CR56","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1359\/jbmr.090209","volume":"24","author":"EF Eriksen","year":"2009","unstructured":"Eriksen EF, Lyles KW, Col\u00f3n-Emeric CS, Pieper CF, Magaziner JS, Adachi JD et al (2009) Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Min Res Official J Am Soc Bone Min Res 24(7):1308\u20131313","journal-title":"J Bone Min Res Official J Am Soc Bone Min Res"},{"key":"6803_CR57","doi-asserted-by":"publisher","first-page":"d7222","DOI":"10.1136\/bmj.d7222","volume":"343","author":"D Prieto-Alhambra","year":"2011","unstructured":"Prieto-Alhambra D, Javaid MK, Judge A, Murray D, Carr A, Cooper C et al (2011) Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 343:d7222","journal-title":"BMJ"},{"issue":"4","key":"6803_CR58","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00198-015-3398-1","volume":"27","author":"F Chen","year":"2016","unstructured":"Chen F, Dai Z, Kang Y, Lv G, Keller ET, Jiang Y (2016) Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int 27(4):1469\u20131476","journal-title":"Osteoporos Int"},{"issue":"6","key":"6803_CR59","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00590-021-03092-z","volume":"32","author":"AA Koutalos","year":"2022","unstructured":"Koutalos AA, Chalatsis GI, Varsanis G, Malizos KN, Karachalios T (2022) The effect of zoledronic acid and high-dose vitamin D on function after hip fractures. A prospective cohort study. Eur J Orthop Surg Traumatol 32(6):1145\u20131152","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"2","key":"6803_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-014-2903-2","volume":"26","author":"YT Li","year":"2015","unstructured":"Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26(2):431\u2013441","journal-title":"Osteoporos Int"},{"key":"6803_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1749-799X-9-45","volume":"9","author":"D Xue","year":"2014","unstructured":"Xue D, Li F, Chen G, Yan S, Pan Z (2014) Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials. J Orthop Surg Res 9:45","journal-title":"J Orthop Surg Res"},{"key":"6803_CR62","doi-asserted-by":"publisher","first-page":"204201882211129","DOI":"10.1177\/20420188221112904","volume":"13","author":"R Palui","year":"2022","unstructured":"Palui R, Durgia H, Sahoo J, Naik D, Kamalanathan S (2022) Timing of osteoporosis therapies following fracture: the current status. Ther Adv Endocrinol Metab 13:20420188221112904","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06803-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06803-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06803-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T09:03:29Z","timestamp":1692090209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06803-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6803"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06803-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We received ethical approval from the Affiliated Kunshan Hospital of Jiangsu University (approval No. 2020-03-046-K01) and was compliant with the Declaration of Helsinki. Patient identification data were hidden from the researchers analyzing the data. Written informed consent was not required because of the investigation\u2019s observational and anonymous design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}